WHC is still in active development. Read this to understand our approach.
depiction of DBGIVFWFUFKIQN-UHFFFAOYSA-N.svg
isomerdesign

Fenfluramine

Check on isomerdesign

pubchem

Fenfluramine

Check on pubchem

pubchem

Dexfenfluramine

Check on pubchem

drugmap

Fenfluramine

Check on drugmap

drugmap

Fenfluramine

Check on drugmap

wiki

Dexfenfluramine

Check on wiki

wiki

Fenfluramine

Check on wiki

wiki

Levofenfluramine

Check on wiki

Data

InChI: InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3

Synonyms: SCHEMBL16215,3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine,Benzeneethanamine, N-ethyl-.alpha.-methyl-3-(trifluoromethyl)-,ZX-008,Fenfluramine d-form,N-Ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine,CHEBI:5000, Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-(9CI),3-(Trifluoromethyl)-N-ethyl-.alpha.-methylphenethylamine,(+)-(S)-N-ETHYL-A-METHYL-M-(TRIFLUOROMETHYL)PHENETHYLAMINE,Prestwick_868, Fenfluramine [INN:BAN],EINECS 207-276-3,Fenfluramine (INN),GTPL4613,N-ETHYL-.ALPHA.-METHYL-M-(TRIFLUOROMETHYL)PHENETHYLAMINE,(+)-Fenfluramine,FENFLURAMINE [MI], Fenfluramine hydrochloride,N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine,Fenfluraminum [INN-Latin], 1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane,ethyl[(2S)-1-[3-(trifluoromethyl)phenyl]propan-2-yl]amine, Adipomin,d-Fenfluramine,Fenfluraminum,N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,Fenfluramine hydrochloride 100 microg/mL in Acetonitrile,DTXSID001025754,Dexfenfluraminum [Latin],J5.760F,NCGC00159473-02,Brabafen, (S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane,N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,L000742, Fenfluramina, N-Ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine,NCGC00247710-01, (S)-Fenfluramine,DL-Fenfluramine,SCHEMBL16706,CHEMBL87493,NCGC00159473-03,CHEBI:439329,Pesos,2-Ethylamino-1-(3-trifluoromethylphenyl)propane, Dexfenfluramine [INN:BAN],NINDS_000980,AC-16024, Dexfenfluramina [Spanish],DSSTox_CID_3044, Ponderex,FENFLURAMINE [INN],Ponderax, Pesos,N-ETHYL-.ALPHA.-METHYL-3-(TRIFLUOROMETHYL)BENZENEETHANAMINE,Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-, Fenfluraminum,DEXFENFLURAN, Redux (TN),Pondimin (Salt/Mix), Ponderax PA,UNII-E35R3G56OV,(S)-(+)-FENFLURAMINE,DEXFENFLURAMINE [INN],Dexfenfluramina,DB00574, Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-(9CI),DSSTox_RID_76850,Rotondin,Adipomin (Salt/Mix),Ponderex (Salt/Mix),(S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,IDI1_000980, N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,(alphaS)-N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine,(S)-Fenfluramine,NSC_65801,Benzeneethanamine, N-ethyl-.alpha.-methyl-3-(trifluoromethyl)-, (S)-,Fenfluramine (-),BRN 4783711,Fenfluramina,Dexfenfluramine [INN:BAN],DEA No. 1670,CAS_16105-77-4,N-Ethyl-1-[3-(trifluoromethyl)phenyl]-2-propanamine #,E35R3G56OV,UNII-2DS058H2CF, Dexfenfluraminum [Latin], 2-Ethylamino-1-(3-trifluoromethylphenyl)propane,Phenethylamine, N-ethyl-alpha-methyl-m-(trifluoromethyl)-,DEXFENFLURAMINE [HSDB], Fenfluraminum [INN-Latin],Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)-Fenfluramine,ZINC294,Phenethylamine, N-ethyl-.alpha.-methyl-m-(trifluoromethyl)-,N-Ethyl-.alpha.-methyl-3-trifluoromethylphenethylamine,ZX008, (2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,FENFLURAMINE [WHO-DD],PDSP2_001403,N-ethyl-1-(3-(trifluoromethyl)phenyl)propan-2-amine,Tox21_111697,Fenfluramine [INN:BAN],Ponderax (TN),NCGC00159473-05,DEXFENFLURAMINE [VANDF], (+)-Fenfluramine,BENZENEETHANAMINE, N-ETHYL-.ALPHA.-METHYL-3-(TRIFLUOROMETHYL)-, (.ALPHA.S)-,DSSTox_GSID_23044,N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine,ethyl({1-[3-(trifluoromethyl)phenyl]propan-2-yl})amine,ip001,Dexfenfluraminum, N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine, Fenfluramine, (+-)-Isomer, Obedrex,KBio1_000980,BDBM84738,(2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,(.ALPHA.S)-N-ETHYL-.ALPHA.-METHYL-3-(TRIFLUOROMETHYL)BENZENEETHANAMINE, 1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane,D07805,Fenfluramin, D-Fenfluramine,CAS-458-24-2,Dextrofenfluramine,Fenfluramina [DCIT],Obedrex,Z-008,Acino,D07945,DEXFENFLURAMINE [WHO-DD],Z008,3239-44-9,S 5614,2DS058H2CF,J13.711A,Q418928,Dexfenfluramina [Spanish],BDBM85596,fenfluraminehydrochloride,S 768,FENFLURAMINE [VANDF],Ethyl-[1-methyl-2-(3-trifluoromethyl-phenyl)-ethyl]-amine,Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)-(9CI),CHEMBL248702,NSC_3337,PDSP1_001419,FENFLURAMINE [HSDB],N-Ethyl-3-(trifluoromethyl)amphetamine,Q3025599,PDSP1_000695, (+/-)-Fenfluramine hydrochloride,C06996,Ponderax PA,fenfluramine, Adifax, S 768,HSDB 3080,Isolipan,DB01191, 3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine, Isomeride,Phenfluramine,Fenfluramine,CAS_3239-45-0,NCGC00159473-04, Fenfluramine (INN),Fenfluramine (+),Dexfenfluramine (INN),D-(+)-FENFLURAMINE,Phenethylamine, N-ethyl-alpha-methyl-m-(trifluoromethyl)-, (S)-, Dexfenfluramine (INN),Dexfenfluramine, Rotondin,Fenfluramine hydrochloride (Salt/Mix),PHENETHYLAMINE, N-ETHYL-.ALPHA.-METHYL-M-(TRIFLUOROMETHYL)-, (S)-,AKOS011892098,N-Ethyl-.alpha.-methyl-m-(trifluoromethyl)phenethylamine hydrochloride (Salt/Mix),DTXSID4023044,PDSP2_000685,458-24-2,S-768, Fenfluramina [DCIT], D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine, Levofenfluramine [INN],Fintepla,Pondimin,(+-)-Fenfluramine,Benzeneethanamine,N-ethyl-alpha-methyl-3-(trifluoromethyl)-, N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine,d-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine,FENFLURAMINE D-FORM [MI],1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane,FT-0770401,Adifax,HSDB 7356, Ponderax (TN),DivK1c_000980


Estimated data

Solubility: -2.533 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 87.1% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.